264 related articles for article (PubMed ID: 17962905)
21. Telaprevir in a patient with chronic hepatitis C and cryoglobulinemic glomerulonephritis.
De Nicola S; Aghemo A; Campise MR; D'Ambrosio R; Rumi MG; Messa P; Colombo M
Antivir Ther; 2014; 19(5):527-31. PubMed ID: 24009104
[TBL] [Abstract][Full Text] [Related]
22. Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial.
Carrat F; Bani-Sadr F; Pol S; Rosenthal E; Lunel-Fabiani F; Benzekri A; Morand P; Goujard C; Pialoux G; Piroth L; Salmon-Céron D; Degott C; Cacoub P; Perronne C;
JAMA; 2004 Dec; 292(23):2839-48. PubMed ID: 15598915
[TBL] [Abstract][Full Text] [Related]
23. Treatment with Peg-interferon alfa-2b and ribavirin of hepatitis C virus-associated mixed cryoglobulinemia.
Saadoun D; Cacoub P
J Hepatol; 2005 Oct; 43(4):737; author reply 738. PubMed ID: 16112770
[No Abstract] [Full Text] [Related]
24. Early HCV RNA changes in patients with chronic hepatitis C treated with peginterferon alfa 2b and ribavirin.
Gallegos-Orozco JF; Fuentes AP; Olivera-Martinez MA; Gutiérrez-Reyes G; Cortina D; Oregel JA; Pérez-Pruna C; Sixtos MS; Cruz-Castellanos S; Soto-Ramírez LE; Rodríguez-Díaz R; Fuentes-Romero L; Gutiérrez-Ruiz MC; Kershenobich D
Rev Invest Clin; 2003; 55(2):138-42. PubMed ID: 12827916
[TBL] [Abstract][Full Text] [Related]
25. Causes and predictive factors of mortality in a cohort of patients with hepatitis C virus-related cryoglobulinemic vasculitis treated with antiviral therapy.
Landau DA; Scerra S; Sene D; Resche-Rigon M; Saadoun D; Cacoub P
J Rheumatol; 2010 Mar; 37(3):615-21. PubMed ID: 20110523
[TBL] [Abstract][Full Text] [Related]
26. Rheumatologic manifestations of Hepatitis C Virus.
Treppo E; Quartuccio L; Ragab G; DE Vita S
Minerva Med; 2021 Apr; 112(2):201-214. PubMed ID: 33263372
[TBL] [Abstract][Full Text] [Related]
27. Response of hepatitis C genotype-4 naïve patients to 24 weeks of Peg-interferon-alpha2b/ribavirin or induction-dose interferon-alpha2b/ribavirin/amantadine: a non-randomized controlled study.
El-Zayadi AR; Attia M; Barakat EM; Badran HM; Hamdy H; El-Tawil A; El-Nakeeb A; Selim O; Saied A
Am J Gastroenterol; 2005 Nov; 100(11):2447-52. PubMed ID: 16279899
[TBL] [Abstract][Full Text] [Related]
28. Extrahepatic manifestations in chronic hepatitis C virus carriers.
Rosenthal E; Cacoub P
Lupus; 2015 Apr; 24(4-5):469-82. PubMed ID: 25801890
[TBL] [Abstract][Full Text] [Related]
29. Sustained exacerbation of cryoglobulinaemia-related vasculitis following treatment of hepatitis C with peginterferon alfa.
Batisse D; Karmochkine M; Jacquot C; Kazatchkine MD; Weiss L
Eur J Gastroenterol Hepatol; 2004 Jul; 16(7):701-3. PubMed ID: 15201585
[TBL] [Abstract][Full Text] [Related]
30. Prospective study of guideline-tailored therapy with direct-acting antivirals for hepatitis C virus-associated mixed cryoglobulinemia.
Gragnani L; Visentini M; Fognani E; Urraro T; De Santis A; Petraccia L; Perez M; Ceccotti G; Colantuono S; Mitrevski M; Stasi C; Del Padre M; Monti M; Gianni E; Pulsoni A; Fiorilli M; Casato M; Zignego AL
Hepatology; 2016 Nov; 64(5):1473-1482. PubMed ID: 27483451
[TBL] [Abstract][Full Text] [Related]
31. Interferon/pegylated interferon and ribavirin in HCV-associated kidney disease with or without cryoglobulinemia.
Bruchfeld A; Lindahl K; Stahle L; Schvarcz R
J Hepatol; 2006 Feb; 44(2):432-3; author reply 433. PubMed ID: 16338023
[No Abstract] [Full Text] [Related]
32. Interferon therapy in HCV-positive mixed cryoglobulinaemia: viral and host factors contributing to efficacy of the therapy.
Mazzaro C; Carniello GS; Colle R; Doretto P; Mazzi G; Crovatto M; Santini GF; Tulissi P; Gregoretti M; Mazzoran L; Russo A; Silvestri F; Pozzato G
Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):343-50. PubMed ID: 9476189
[TBL] [Abstract][Full Text] [Related]
33. A comparison of the exponential decay slope between PEG-IFN alfa-2b/ribavirin and IFN alfa-2b/ribavirin combination therapy in patients with chronic hepatitis C genotype 1b infection and a high viral load.
Izumi N; Asahina Y; Kurosaki M; Uchihara M; Nishimura Y; Inoue K; Ueda K; Tsuchiya K; Hamano K; Itakura J; Miyake S
Intervirology; 2004; 47(2):102-7. PubMed ID: 15192274
[TBL] [Abstract][Full Text] [Related]
34. Treatment of genotype 1b HCV-related chronic hepatitis: efficacy and toxicity of three different interferon alfa-2b/ribavirin combined regimens in naive patients.
Scotto G; Fazio V; Palumbo E; Cibelli DC; Saracino A; Angarano G
New Microbiol; 2005 Jan; 28(1):23-9. PubMed ID: 15782623
[TBL] [Abstract][Full Text] [Related]
35. Antiviral therapy for cryoglobulinemic neuropathy: comment on the article by Saadoun et al.
Gemignani F; Brindani F; Marbini A
Arthritis Rheum; 2007 Aug; 56(8):2810; author reply 2810-1. PubMed ID: 17665398
[No Abstract] [Full Text] [Related]
36. Complete remission of cryoglobulinemic glomerulonephritis (HCV-positive) after high dose interferon therapy.
Laganović M; Jelaković B; Kuzmanić D; Sćukanec-Spoljar M; Roncević T; Cuzić S; Ostojić R
Wien Klin Wochenschr; 2000 Jul; 112(13):596-600. PubMed ID: 10944819
[TBL] [Abstract][Full Text] [Related]
37. Etiologic treatment of hepatitis C virus-associated mixed cryoglobulinemia.
Mazzaro C; Pozzato G; Zorat F; Baragiotta AM; Biscontin MG; Spina M; Tirelli U
Dig Liver Dis; 2007 Sep; 39 Suppl 1():S102-6. PubMed ID: 17936209
[TBL] [Abstract][Full Text] [Related]
38. Effects of combined antiviral therapy on asymptomatic mixed cryoglobulinemia in naive patients with chronic hepatitis C virus infection: a preliminary study.
D'Amico E; Chincoli C; Cacciatore P; di Pasqua G; Cosentino L; Riario-Sforza G; Pennese E; Capani F; Palazzi C
Dig Dis Sci; 2005 Dec; 50(12):2344-7. PubMed ID: 16416186
[TBL] [Abstract][Full Text] [Related]
39. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.
Fried MW; Shiffman ML; Reddy KR; Smith C; Marinos G; Gonçales FL; Häussinger D; Diago M; Carosi G; Dhumeaux D; Craxi A; Lin A; Hoffman J; Yu J
N Engl J Med; 2002 Sep; 347(13):975-82. PubMed ID: 12324553
[TBL] [Abstract][Full Text] [Related]
40. Treatment of hepatitis C virus-associated inflammatory polyneuropathy with pegylated interferon-alpha and ribavirin.
Trebst C; Wedemeyer H; Manns MP; Tillmann H; Windhagen A
Eur J Gastroenterol Hepatol; 2007 Jan; 19(1):91-2. PubMed ID: 17206084
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
